Tag: viral

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

byLori Laiand1 others

September 24, 2026

1. In this large randomized controlled trial, patients with human immunodeficiency virus (HIV) who received long-acting broadly neutralizing antibodies were ...

#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes

byConstance Wu

March 10, 2021

1. Tocilizumab reduced the need for mechanical ventilation and lowered death outcomes in patients infected with severe acute respiratory syndrome ...

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: viral

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits